Eye drops
Composition:
1 ml of eye drops, solution, contains 0.5 mg of epinastine hydrochloride. (equivalent to 0.436 mg epinastine) Excipient: benzalkonium chloride 0.1 mg/ml For the full list of excipients, see section 6.1.
Excipients
Benzalkonium chloride, disodium edetate, sodium chloride, sodium phosphate monobasic dihydrate, sodium hydroxide/hydrochloric acid (for pH adjustment), purified water.
Therapeutic indications
Symptomatic treatment of seasonal allergic conjunctivitis.
Contraindications
Hypersensitivity to epinastine or to any of the excipients.
Posology
In adults, the recommended dose is one drop instilled in each affected eye twice daily, during the symptomatic phase. No data from clinical studies are available on the use of Relestat for periods longer than 8 weeks. To avoid contaminating the eye or the eye drops, the dropper tip should not come into contact with any surface. If multiple topical ophthalmic products are used together, administer the different drugs at least 10 minutes apart. Use in the elderly Relestat has not been studied in elderly patients. Post-marketing data on the safety of epinastine hydrochloride tablets (administered once daily up to a dosage of 20 mg) have indicated that there are no particular safety concerns in elderly patients compared to adult patients. Therefore, no dosage adjustment is considered necessary. Use in the pediatric population Safety and efficacy in patients aged
Product Code:FRCM046578
Price Trend
This product has been on sale since 25/09/2017
In the last 30 days, the product's lowest price
was 16,56 €
Richiedi info sul prodotto
